These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Angiogenic imbalance and plasma lipid alterations in women with preeclampsia from a developing country. Reyes LM; García RG; Ruiz SL; Broadhurst D; Aroca G; Davidge ST; López-Jaramillo P Growth Factors; 2012 Jun; 30(3):158-66. PubMed ID: 22486210 [TBL] [Abstract][Full Text] [Related]
30. LIFR increases the release of soluble endoglin via the upregulation of MMP14 expression in preeclampsia. Li H; Yao J; Chang X; Wu J; Duan T; Wang K Reproduction; 2018 Mar; 155(3):297-306. PubMed ID: 29363569 [TBL] [Abstract][Full Text] [Related]
31. Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia. Rădulescu C; Bacârea A; Huțanu A; Gabor R; Dobreanu M Mediators Inflamm; 2016; 2016():3027363. PubMed ID: 27799724 [TBL] [Abstract][Full Text] [Related]
32. Multiple Soluble TGF-β Receptors in Addition to Soluble Endoglin Are Elevated in Preeclamptic Serum and They Synergistically Inhibit TGF-β Signaling. Wang Y; Chen Q; Zhao M; Walton K; Harrison C; Nie G J Clin Endocrinol Metab; 2017 Aug; 102(8):3065-3074. PubMed ID: 28633389 [TBL] [Abstract][Full Text] [Related]
33. Maternal serum soluble endoglin at 30-33 weeks in the prediction of preeclampsia. Lai J; Syngelaki A; Poon LC; Nucci M; Nicolaides KH Fetal Diagn Ther; 2013; 33(3):149-55. PubMed ID: 23154616 [TBL] [Abstract][Full Text] [Related]
34. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia. Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962 [TBL] [Abstract][Full Text] [Related]
36. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells. Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692 [TBL] [Abstract][Full Text] [Related]
37. Review: the enigmatic role of endoglin in the placenta. Gregory AL; Xu G; Sotov V; Letarte M Placenta; 2014 Feb; 35 Suppl():S93-9. PubMed ID: 24252708 [TBL] [Abstract][Full Text] [Related]
38. High soluble endoglin levels do not induce changes in structural parameters of mouse heart. Rathouska J; Fikrova P; Mrkvicova A; Blazickova K; Varejckova M; Dolezelova E; Nemeckova I; Vitverova B; Peslova L; Gallardo-Vara E; Pericacho M; Nachtigal P Heart Vessels; 2017 Aug; 32(8):1013-1024. PubMed ID: 28382387 [TBL] [Abstract][Full Text] [Related]
40. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]